Dow Up 1.31% Nasdaq Up 2.40%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.51 0.45(11.08%) Oct 21, 4:00PM EDT
|Pre-Market : 4.61 Up 0.10 (2.22%) 8:03AM EDT - Nasdaq Real Time Price
Prev Close:4.06
Open:4.16
Bid:4.58 x 1000
Ask:4.61 x 600
1y Target Est:11.00
Beta:3.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.16 - 4.95
52wk Range:3.11 - 7.82
Volume:8,780,683
Avg Vol (3m):4,097,210
Market Cap:552.63M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXUp 11.08%552.63M
ABT63.74B
GSK104.80B
RHHBY247.27B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):145.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback